1 Study Coverage
1.1 Ophthalmic Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Ophthalmic Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Implantable Ophthalmic Drug Delivery Systems
1.2.3 Particulate Ophthalmic Drug Delivery Systems
1.2.4 Others
1.3 Market by Application
1.3.1 Global Ophthalmic Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Drug Delivery System Sales Estimates and Forecasts 2017-2028
2.2 Global Ophthalmic Drug Delivery System Revenue Estimates and Forecasts 2017-2028
2.3 Global Ophthalmic Drug Delivery System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ophthalmic Drug Delivery System Sales by Region
2.4.1 Global Ophthalmic Drug Delivery System Sales by Region (2017-2022)
2.4.2 Global Sales Ophthalmic Drug Delivery System by Region (2023-2028)
2.5 Global Ophthalmic Drug Delivery System Revenue by Region
2.5.1 Global Ophthalmic Drug Delivery System Revenue by Region (2017-2022)
2.5.2 Global Ophthalmic Drug Delivery System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ophthalmic Drug Delivery System Sales by Manufacturers
3.1.1 Global Top Ophthalmic Drug Delivery System Manufacturers by Sales (2017-2022)
3.1.2 Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ophthalmic Drug Delivery System in 2021
3.2 Global Ophthalmic Drug Delivery System Revenue by Manufacturers
3.2.1 Global Ophthalmic Drug Delivery System Revenue by Manufacturers (2017-2022)
3.2.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ophthalmic Drug Delivery System Revenue in 2021
3.3 Global Ophthalmic Drug Delivery System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ophthalmic Drug Delivery System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ophthalmic Drug Delivery System Sales by Type
4.1.1 Global Ophthalmic Drug Delivery System Historical Sales by Type (2017-2022)
4.1.2 Global Ophthalmic Drug Delivery System Forecasted Sales by Type (2023-2028)
4.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
4.2 Global Ophthalmic Drug Delivery System Revenue by Type
4.2.1 Global Ophthalmic Drug Delivery System Historical Revenue by Type (2017-2022)
4.2.2 Global Ophthalmic Drug Delivery System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
4.3 Global Ophthalmic Drug Delivery System Price by Type
4.3.1 Global Ophthalmic Drug Delivery System Price by Type (2017-2022)
4.3.2 Global Ophthalmic Drug Delivery System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ophthalmic Drug Delivery System Sales by Application
5.1.1 Global Ophthalmic Drug Delivery System Historical Sales by Application (2017-2022)
5.1.2 Global Ophthalmic Drug Delivery System Forecasted Sales by Application (2023-2028)
5.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
5.2 Global Ophthalmic Drug Delivery System Revenue by Application
5.2.1 Global Ophthalmic Drug Delivery System Historical Revenue by Application (2017-2022)
5.2.2 Global Ophthalmic Drug Delivery System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
5.3 Global Ophthalmic Drug Delivery System Price by Application
5.3.1 Global Ophthalmic Drug Delivery System Price by Application (2017-2022)
5.3.2 Global Ophthalmic Drug Delivery System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ophthalmic Drug Delivery System Market Size by Type
6.1.1 North America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
6.1.2 North America Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
6.2 North America Ophthalmic Drug Delivery System Market Size by Application
6.2.1 North America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
6.2.2 North America Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
6.3 North America Ophthalmic Drug Delivery System Market Size by Country
6.3.1 North America Ophthalmic Drug Delivery System Sales by Country (2017-2028)
6.3.2 North America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ophthalmic Drug Delivery System Market Size by Type
7.1.1 Europe Ophthalmic Drug Delivery System Sales by Type (2017-2028)
7.1.2 Europe Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Drug Delivery System Market Size by Application
7.2.1 Europe Ophthalmic Drug Delivery System Sales by Application (2017-2028)
7.2.2 Europe Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Drug Delivery System Market Size by Country
7.3.1 Europe Ophthalmic Drug Delivery System Sales by Country (2017-2028)
7.3.2 Europe Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Drug Delivery System Market Size by Type
8.1.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Type (2017-2028)
8.1.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
8.2 Asia Pacific Ophthalmic Drug Delivery System Market Size by Application
8.2.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Application (2017-2028)
8.2.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
8.3 Asia Pacific Ophthalmic Drug Delivery System Market Size by Region
8.3.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2017-2028)
8.3.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ophthalmic Drug Delivery System Market Size by Type
9.1.1 Latin America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
9.1.2 Latin America Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
9.2 Latin America Ophthalmic Drug Delivery System Market Size by Application
9.2.1 Latin America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
9.2.2 Latin America Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
9.3 Latin America Ophthalmic Drug Delivery System Market Size by Country
9.3.1 Latin America Ophthalmic Drug Delivery System Sales by Country (2017-2028)
9.3.2 Latin America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Type
10.1.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
10.2 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Application
10.2.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
10.3 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country
10.3.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aero Pump GmbH
11.1.1 Aero Pump GmbH Corporation Information
11.1.2 Aero Pump GmbH Overview
11.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aero Pump GmbH Recent Developments
11.2 AptarGroup
11.2.1 AptarGroup Corporation Information
11.2.2 AptarGroup Overview
11.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AptarGroup Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AptarGroup Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Corporation Information
11.3.2 Bausch Health Overview
11.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bausch Health Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bausch Health Recent Developments
11.4 Becton Dickinson & Company
11.4.1 Becton Dickinson & Company Corporation Information
11.4.2 Becton Dickinson & Company Overview
11.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Becton Dickinson & Company Recent Developments
11.5 EyePoint Pharmaceuticals, Inc.
11.5.1 EyePoint Pharmaceuticals, Inc. Corporation Information
11.5.2 EyePoint Pharmaceuticals, Inc. Overview
11.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments
11.6 Gaplast GmbH
11.6.1 Gaplast GmbH Corporation Information
11.6.2 Gaplast GmbH Overview
11.6.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Gaplast GmbH Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Gerresheimer Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gerresheimer Recent Developments
11.8 Nemera
11.8.1 Nemera Corporation Information
11.8.2 Nemera Overview
11.8.3 Nemera Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nemera Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nemera Recent Developments
11.9 Nipro Corporation
11.9.1 Nipro Corporation Corporation Information
11.9.2 Nipro Corporation Overview
11.9.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Nipro Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nipro Corporation Recent Developments
11.10 Ocular Therapeutix
11.10.1 Ocular Therapeutix Corporation Information
11.10.2 Ocular Therapeutix Overview
11.10.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ocular Therapeutix Recent Developments
11.11 Owen Mumford
11.11.1 Owen Mumford Corporation Information
11.11.2 Owen Mumford Overview
11.11.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Owen Mumford Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Owen Mumford Recent Developments
11.12 Silgan Holdings Inc.
11.12.1 Silgan Holdings Inc. Corporation Information
11.12.2 Silgan Holdings Inc. Overview
11.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Silgan Holdings Inc. Recent Developments
11.13 Terumo Corporation
11.13.1 Terumo Corporation Corporation Information
11.13.2 Terumo Corporation Overview
11.13.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Terumo Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Terumo Corporation Recent Developments
11.14 West Pharmaceutical Services, Inc.
11.14.1 West Pharmaceutical Services, Inc. Corporation Information
11.14.2 West Pharmaceutical Services, Inc. Overview
11.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 West Pharmaceutical Services, Inc. Recent Developments
11.15 Kedalion Therapeutics
11.15.1 Kedalion Therapeutics Corporation Information
11.15.2 Kedalion Therapeutics Overview
11.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Kedalion Therapeutics Recent Developments
11.16 Re-Vana Therapeutics
11.16.1 Re-Vana Therapeutics Corporation Information
11.16.2 Re-Vana Therapeutics Overview
11.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Re-Vana Therapeutics Recent Developments
11.17 Mati Therapeutics, Inc.,
11.17.1 Mati Therapeutics, Inc., Corporation Information
11.17.2 Mati Therapeutics, Inc., Overview
11.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mati Therapeutics, Inc., Recent Developments
11.18 Biocorp Production
11.18.1 Biocorp Production Corporation Information
11.18.2 Biocorp Production Overview
11.18.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Biocorp Production Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Biocorp Production Recent Developments
11.19 Ocumedic, Inc.
11.19.1 Ocumedic, Inc. Corporation Information
11.19.2 Ocumedic, Inc. Overview
11.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Ocumedic, Inc. Recent Developments
11.20 Graybug Vision
11.20.1 Graybug Vision Corporation Information
11.20.2 Graybug Vision Overview
11.20.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Graybug Vision Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Graybug Vision Recent Developments
11.21 Taiwan Liposome
11.21.1 Taiwan Liposome Corporation Information
11.21.2 Taiwan Liposome Overview
11.21.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Taiwan Liposome Recent Developments
11.22 Santen Pharmaceutical
11.22.1 Santen Pharmaceutical Corporation Information
11.22.2 Santen Pharmaceutical Overview
11.22.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Santen Pharmaceutical Recent Developments
11.23 Envisia Therapeutics
11.23.1 Envisia Therapeutics Corporation Information
11.23.2 Envisia Therapeutics Overview
11.23.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Envisia Therapeutics Recent Developments
11.24 Clearside Biomedical
11.24.1 Clearside Biomedical Corporation Information
11.24.2 Clearside Biomedical Overview
11.24.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Clearside Biomedical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ophthalmic Drug Delivery System Industry Chain Analysis
12.2 Ophthalmic Drug Delivery System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ophthalmic Drug Delivery System Production Mode & Process
12.4 Ophthalmic Drug Delivery System Sales and Marketing
12.4.1 Ophthalmic Drug Delivery System Sales Channels
12.4.2 Ophthalmic Drug Delivery System Distributors
12.5 Ophthalmic Drug Delivery System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ophthalmic Drug Delivery System Industry Trends
13.2 Ophthalmic Drug Delivery System Market Drivers
13.3 Ophthalmic Drug Delivery System Market Challenges
13.4 Ophthalmic Drug Delivery System Market Restraints
14 Key Findings in The Global Ophthalmic Drug Delivery System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer